Search for a trial

A Phase III randomized, double blind, placebo controlled, multicenter study of panobinostat for maintenance of response in patients with Hodgkinâ¤*s lymphoma who are at risk for relapse after high dose chemotherapy and autologous stem cell transplant

Primary* To compare the disease free survival (DFS) in patients with HL after achieving a complete response following AHSCT with HDT who are treated with panobinostat versus those who receive placebo based on investigator*s review of radiological…

Improving sleep quality, psychosocial functioning, and cancer related fatigue with light therapy (SPARKLE-study).

(1) To examine whether the exposure to BWL yields clinically significant reductions in CRF compared to exposure to dim white light in (non-)Hodgkin survivors. (2) To examine the effect of exposure to BWL compared to DWL on sleep quality and…